• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于高通量连续流生产超高载药量纳米药物的多酚-氨基酸缩合物文库。

A Library of Polyphenol-Amino Acid Condensates for High-Throughput Continuous Flow Production of Nanomedicines with Ultra-High Drug Loading.

作者信息

Yi Zeng, Ma Xiaomin, Tong Qiulan, Ma Lei, Tan Yunfei, Liu Danni, Tan Chaoliang, Chen Junze, Li Xudong

机构信息

National Engineering Research Center for Biomaterials, Sichuan University, Chengdu, 610064, P. R. China.

College of Biomedical Engineering, Sichuan University, Chengdu, 610064, P. R. China.

出版信息

Adv Mater. 2025 Apr;37(15):e2417534. doi: 10.1002/adma.202417534. Epub 2025 Feb 3.

DOI:10.1002/adma.202417534
PMID:39901461
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12004891/
Abstract

Synthesizing high drug-loading nanomedicines remains a formidable challenge, and achieving universally applicable, continuous, large-scale engineered production of such nanomedicines presents even greater difficulties. This study presents a scalable library of polyphenol-amino acid condensates. By selecting amino acids, the library enables precise customization of key properties, such as carrier capacity, bioactivity, and other critical attributes, offering a versatile range of options for various application scenarios. Leveraging the properties of solvent-mediated disassembly and reassembly of condensates achieved an ultra-high drug loading of 86% for paclitaxel. For a range of poorly soluble molecules, the drug loading capacity exceeded 50%, indicating broad applicability. Furthermore, employing a continuous microfluidic device, the production rate can reach 5 mL min (36 g per day), with the nanoparticle size precisely tunable and a polydispersity index (PDI) below 0.2. The polyphenol-based carrier demonstrates efficient cellular uptake and, in three distinct animal models, has been shown to enhance the therapeutic efficacy of paclitaxel without significant side effects. This study presents a streamlined, efficient, and scalable approach using microfluidics to produce nanomedicines with ultra-high drug loading, offering a promising strategy for the nanoformulation of poorly soluble drugs.

摘要

合成高载药量的纳米药物仍然是一项艰巨的挑战,而实现这种纳米药物的普遍适用、连续、大规模工程化生产则面临更大的困难。本研究展示了一个可扩展的多酚-氨基酸缩合物库。通过选择氨基酸,该库能够精确定制关键特性,如载药量、生物活性和其他关键属性,为各种应用场景提供了广泛的选择。利用缩合物的溶剂介导拆卸和重新组装特性,实现了紫杉醇86%的超高载药量。对于一系列难溶性分子,载药能力超过50%,表明其具有广泛的适用性。此外,采用连续微流控装置,生产速率可达5 mL/分钟(每天36克),纳米颗粒尺寸可精确调节,多分散指数(PDI)低于0.2。基于多酚的载体显示出高效的细胞摄取,并且在三种不同的动物模型中,已证明其能增强紫杉醇的治疗效果且无明显副作用。本研究提出了一种使用微流控技术生产超高载药量纳米药物的简化、高效且可扩展的方法,为难溶性药物的纳米制剂提供了一种有前景的策略。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/91fd/12004891/54aa63d38a87/ADMA-37-2417534-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/91fd/12004891/d422223d135d/ADMA-37-2417534-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/91fd/12004891/9effc11edb6f/ADMA-37-2417534-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/91fd/12004891/a2c68b968e42/ADMA-37-2417534-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/91fd/12004891/71332a61d80b/ADMA-37-2417534-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/91fd/12004891/5493f11a638b/ADMA-37-2417534-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/91fd/12004891/b1a1a1bc4432/ADMA-37-2417534-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/91fd/12004891/f1e07a0d1346/ADMA-37-2417534-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/91fd/12004891/54aa63d38a87/ADMA-37-2417534-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/91fd/12004891/d422223d135d/ADMA-37-2417534-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/91fd/12004891/9effc11edb6f/ADMA-37-2417534-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/91fd/12004891/a2c68b968e42/ADMA-37-2417534-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/91fd/12004891/71332a61d80b/ADMA-37-2417534-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/91fd/12004891/5493f11a638b/ADMA-37-2417534-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/91fd/12004891/b1a1a1bc4432/ADMA-37-2417534-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/91fd/12004891/f1e07a0d1346/ADMA-37-2417534-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/91fd/12004891/54aa63d38a87/ADMA-37-2417534-g003.jpg

相似文献

1
A Library of Polyphenol-Amino Acid Condensates for High-Throughput Continuous Flow Production of Nanomedicines with Ultra-High Drug Loading.用于高通量连续流生产超高载药量纳米药物的多酚-氨基酸缩合物文库。
Adv Mater. 2025 Apr;37(15):e2417534. doi: 10.1002/adma.202417534. Epub 2025 Feb 3.
2
General Nanomedicine Platform by Solvent-Mediated Disassembly/Reassembly of Scalable Natural Polyphenol Colloidal Spheres.溶剂介导的可扩展天然多酚胶体球的解体/重组的通用纳米医学平台。
ACS Appl Mater Interfaces. 2020 Aug 26;12(34):37914-37928. doi: 10.1021/acsami.0c11650. Epub 2020 Aug 14.
3
Machine Learning-Driven Prediction, Preparation, and Evaluation of Functional Nanomedicines Via Drug-Drug Self-Assembly.通过药物-药物自组装实现机器学习驱动的功能性纳米药物预测、制备与评估
Adv Sci (Weinh). 2025 Mar;12(9):e2415902. doi: 10.1002/advs.202415902. Epub 2025 Jan 10.
4
High drug-loading nanomedicines: progress, current status, and prospects.高载药量纳米药物:进展、现状与展望
Int J Nanomedicine. 2017 May 31;12:4085-4109. doi: 10.2147/IJN.S132780. eCollection 2017.
5
Using microfluidics for scalable manufacturing of nanomedicines from bench to GMP: A case study using protein-loaded liposomes.利用微流控技术从实验室到 GMP 规模生产纳米药物:以载蛋白脂质体为例。
Int J Pharm. 2020 May 30;582:119266. doi: 10.1016/j.ijpharm.2020.119266. Epub 2020 Apr 3.
6
Paclitaxel dimers assembling nanomedicines for treatment of cervix carcinoma.紫杉醇二聚体组装纳米药物治疗宫颈癌。
J Control Release. 2017 May 28;254:23-33. doi: 10.1016/j.jconrel.2017.03.391. Epub 2017 Mar 27.
7
Preparation of Strong Antioxidative, Therapeutic Nanoparticles Based on Amino Acid-Induced Ultrafast Assembly of Tea Polyphenols.基于氨基酸诱导的茶多芬超快组装制备强抗氧化、治疗性纳米粒子。
ACS Appl Mater Interfaces. 2020 Jul 29;12(30):33550-33563. doi: 10.1021/acsami.0c10282. Epub 2020 Jul 15.
8
Microfluidics-Assembled Nanovesicles for Nucleic Acid Delivery.用于核酸递送的微流控组装纳米囊泡
Acc Chem Res. 2025 Feb 18;58(4):570-582. doi: 10.1021/acs.accounts.4c00738. Epub 2025 Feb 4.
9
Developing Precisely Defined Drug-Loaded Nanoparticles by Ring-Opening Polymerization of a Paclitaxel Prodrug.通过紫杉醇前药的开环聚合制备精确定义的载药纳米颗粒。
Adv Healthc Mater. 2016 Aug;5(15):1868-73. doi: 10.1002/adhm.201600230. Epub 2016 Apr 25.
10
Challenges and opportunities of poly(amino acid) nanomedicines in cancer therapy.聚(氨基酸)纳米药物在癌症治疗中的挑战与机遇。
Nanomedicine (Lond). 2024;19(29):2495-2504. doi: 10.1080/17435889.2024.2402677. Epub 2024 Oct 9.

本文引用的文献

1
Tea polyphenol carrier-enhanced dexamethasone nanomedicines for inflammation-targeted treatment of rheumatoid arthritis.茶多酚载体增强型地塞米松纳米药物用于类风湿关节炎的炎症靶向治疗
J Mater Chem B. 2023 Dec 13;11(48):11505-11518. doi: 10.1039/d3tb02316h.
2
High-Dose Paclitaxel and its Combination with CSF1R Inhibitor in Polymeric Micelles for Chemoimmunotherapy of Triple Negative Breast Cancer.高剂量紫杉醇及其与CSF1R抑制剂在聚合物胶束中联合用于三阴性乳腺癌的化学免疫治疗
Nano Today. 2023 Aug;51. doi: 10.1016/j.nantod.2023.101884. Epub 2023 Jun 1.
3
Molecular bottlebrush prodrugs as mono- and triplex combination therapies for multiple myeloma.
分子刷型前药作为单药和三联组合疗法治疗多发性骨髓瘤。
Nat Nanotechnol. 2023 Feb;18(2):184-192. doi: 10.1038/s41565-022-01310-1. Epub 2023 Jan 26.
4
Cancer nanomedicine.癌症纳米医学。
Nat Rev Cancer. 2022 Oct;22(10):550-556. doi: 10.1038/s41568-022-00496-9. Epub 2022 Aug 8.
5
Clinical translation of nanomedicines: Challenges, opportunities, and keys.纳米药物的临床转化:挑战、机遇与要点。
Adv Drug Deliv Rev. 2022 Feb;181:114083. doi: 10.1016/j.addr.2021.114083. Epub 2021 Dec 17.
6
Potential protective mechanisms of green tea polyphenol EGCG against COVID-19.绿茶多酚表没食子儿茶素没食子酸酯(EGCG)对2019冠状病毒病(COVID-19)的潜在保护机制
Trends Food Sci Technol. 2021 Aug;114:11-24. doi: 10.1016/j.tifs.2021.05.023. Epub 2021 May 25.
7
Computationally guided high-throughput design of self-assembling drug nanoparticles.计算指导的自组装药物纳米粒高通量设计。
Nat Nanotechnol. 2021 Jun;16(6):725-733. doi: 10.1038/s41565-021-00870-y. Epub 2021 Mar 25.
8
Emerging pharmaceutical therapies for osteoarthritis.骨关节炎的新兴药物疗法。
Nat Rev Rheumatol. 2020 Dec;16(12):673-688. doi: 10.1038/s41584-020-00518-6. Epub 2020 Oct 29.
9
General Nanomedicine Platform by Solvent-Mediated Disassembly/Reassembly of Scalable Natural Polyphenol Colloidal Spheres.溶剂介导的可扩展天然多酚胶体球的解体/重组的通用纳米医学平台。
ACS Appl Mater Interfaces. 2020 Aug 26;12(34):37914-37928. doi: 10.1021/acsami.0c11650. Epub 2020 Aug 14.
10
Combination of microfluidic chip and electrostatic atomization for the preparation of drug-loaded core-shell nanoparticles.微流控芯片与静电雾化联用制备载药核壳纳米粒。
Nanotechnology. 2020 Apr 3;31(14):145301. doi: 10.1088/1361-6528/ab6236. Epub 2019 Dec 16.